These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22237583)

  • 21. Structural remodeling in atrial fibrillation.
    Corradi D; Callegari S; Maestri R; Benussi S; Alfieri O
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):782-96. PubMed ID: 18852714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of angiotensin converting enzyme II is associated with pacing-induced sustained atrial fibrillation.
    Pan CH; Lin JL; Lai LP; Chen CL; Stephen Huang SK; Lin CS
    FEBS Lett; 2007 Feb; 581(3):526-34. PubMed ID: 17254576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes.
    Yeh YH; Kuo CT; Chan TH; Chang GJ; Qi XY; Tsai F; Nattel S; Chen WJ
    Cardiovasc Res; 2011 Jul; 91(1):62-70. PubMed ID: 21289011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines.
    Shan H; Zhang Y; Lu Y; Zhang Y; Pan Z; Cai B; Wang N; Li X; Feng T; Hong Y; Yang B
    Cardiovasc Res; 2009 Aug; 83(3):465-72. PubMed ID: 19398468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tryptase Promotes the Profibrotic Phenotype Transfer of Atrial Fibroblasts by PAR2 and PPARγ Pathway.
    Tan H; Chen Z; Chen F; Yao Y; Lai Y; Xu W; Liu X
    Arch Med Res; 2018 Nov; 49(8):568-575. PubMed ID: 30580879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial structural remodeling as an antiarrhythmic target.
    Burstein B; Nattel S
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):4-10. PubMed ID: 18594481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria.
    Eckstein J; Verheule S; de Groot NM; Allessie M; Schotten U
    Prog Biophys Mol Biol; 2008; 97(2-3):435-51. PubMed ID: 18378284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Electrophysiologic mechanisms of atrial fibrillation].
    Brugada J
    Rev Esp Cardiol; 1996; 49 Suppl 2():8-12. PubMed ID: 8755691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.
    Nakano Y; Niida S; Dote K; Takenaka S; Hirao H; Miura F; Ishida M; Shingu T; Sueda T; Yoshizumi M; Chayama K
    J Am Coll Cardiol; 2004 Mar; 43(5):818-25. PubMed ID: 14998623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation: insights from clinical trials and novel treatment options.
    Blaauw Y; Crijns HJ
    J Intern Med; 2007 Dec; 262(6):593-614. PubMed ID: 18028181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory pathways underlying atrial fibrillation.
    Friedrichs K; Klinke A; Baldus S
    Trends Mol Med; 2011 Oct; 17(10):556-63. PubMed ID: 21763201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta1: a possible risk stratification tool for atrial fibrillation.
    Sovari AA; Kocheril AG
    Med Hypotheses; 2008; 71(1):149-50. PubMed ID: 18329183
    [No Abstract]   [Full Text] [Related]  

  • 34. Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases.
    Qian Y; Meng J; Tang H; Yang G; Deng Y; Wei D; Xiang B; Xiao X
    Europace; 2010 Mar; 12(3):371-7. PubMed ID: 20106797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Remodelling in atrial fibrillation].
    Lévy S; Sbragia P
    Arch Mal Coeur Vaiss; 2005 Apr; 98(4):308-12. PubMed ID: 15881846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-ion channel blockers as anti-arrhythmic drugs (reversal of structural remodeling).
    Goette A; Bukowska A; Lendeckel U
    Curr Opin Pharmacol; 2007 Apr; 7(2):219-24. PubMed ID: 17276728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of atrial fibrosis: implications for the clinic.
    Thanigaimani S; Lau DH; Agbaedeng T; Elliott AD; Mahajan R; Sanders P
    Expert Rev Cardiovasc Ther; 2017 Apr; 15(4):247-256. PubMed ID: 28271726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in atrial perfusion during atrial fibrillation.
    Pacchia CF; Dosdall DJ; Ranjan R; DiBella E
    Exp Physiol; 2014 Oct; 99(10):1267-72. PubMed ID: 25063838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential gene expression during atrial structural remodeling in human left and right atrial appendages in atrial fibrillation.
    Zhu H; Zhang W; Zhong M; Zhang G; Zhang Y
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):535-41. PubMed ID: 21659381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.